Studien

BEAT-HF

Better Effectiveness After Transition-Heart Failure

BEAT-HFpEF

Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF

BEAT-LUPUS

Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus

BEAT-meso

Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma

BEAT-ROP

Bevacizumab Eliminates the Angiogenic Threat of Retinopathy of Prematurity

BEAT-Stroke

Biomarker Evaluation for Antioxidant Therapies in Stroke

BEATcc

Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix

BEATRICE

Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer

BEATS

Balanced Evaluation of Atrial Tachyarrhythmias in Stimulated Patients Study

BEAUTIFUL

MorBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction study

Beaver Dam Eye Study

Beaver Dam Eye Study is a longitudinal population-based study of age-related eye diseases conducted in the city and township of Beaver Dam, Wisconsin

BeBop

Bipolar haemostatic forceps versus standard therapy by haemoclip + / − epinephrine injection as initial endoscopic treatment in active non-variceal upper GI bleeding: study protocol for a prospective, randomized multicentre trial

BEBYP

BEvacizumab BeYond Progression

BECAIT

BEzafibrate Coronary Atherosclerosis Intervention Trial

BECCTS

Benign Epilepsy of Childhood with Centrotemporal Spikes

BECOME

BEtaseron COpaxone in Multiple sclerosis with triple-dose gadolinium and 3-Tesla MRI Endpoints

BEDIVERE

A Safety and Pharmacokinetics Study of Niraparib Plus an Androgen Receptor-Targeted Therapy in Men With Metastatic Castration-Resistant Prostate Cancer

BedMed-Frail

Does the potential benefit of bedtime antihypertensive prescribing extend to frail populations?

BEDS

Brescia Early Defibrillation Study

BEED

The Bangladesh Environmental Enteric Dysfunction Study

BEEP

Barrier Enhancement for Eczema Prevention

BEER BTC

Bevacizumab Erlotinib Switch Maintenance in Chemo-Responsive Advanced Gallbladder and Cholangiocarcinoma

beFIT

Boeing Employee Fat Intervention Trial

BEFORE THE BEGINNING

Preconception Lifestyle Interventions to Improve Future Metabolic Health

BEGIN

Behavioral Nudges for Diabetes Prevention

BEGIN

Breastmilk Ecology: Genesis of Infant Nutrition

BEGIN

Bridging Educational Grant in Nursing students' intentions for retention in long-term, home and community care

BEGIN Basal-Bolus Type 1

Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 Diabetes

BEGIN Basal-Bolus Type 2

Insulin degludec as basal-bolus therapy (study B)

BEGIN LOW VOLUME

Comparison of NN1250 with insulin glargine in subjects with type 2 diabetes (BEGIN™) trial

BEGIN Once Long

Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial

BEGIN: VICTOZA ADD-ON

A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes

BEGIN:EASY PM

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

BEGIN™

A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes

BEGONIA

Efficacy of flibanserin in women with hypoactive sexual desire disorder

BEGUT-CYPHER

BEta versus Gamma Utrecht Trial

BEH

Bushehr Elderly Health program

BEHoLD Al463022

Benefits of Entecavir for Hepatitis B Liver Disease Al463022

BEHoLD Al463026

Benefits of Entecavir for Hepatitis B Liver Disease Al463026

BEHoLD Al463027

Benefits of Entecavir for Hepatitis B Liver Disease Al463027

beijerinck

Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia

BELCOMID

BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases (IMID)

BELFRAIL

A population-based prospective cohort study of the very elderly in Belgium

BELIEF

Left Atrial Appendage Isolation in Patients With Longstanding Persistent AF Undergoing Catheter Ablation

BELIEVE

An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia

BELIEVE

Bi versus Left Ventricular Pacing, an Italian Evaluation on Heart Failure with Ventricular Arrhythmias

BELIEVE

Platform trial for off-label oncology drugs using comprehensive genomic profiling under the universal public healthcare system

BELISS

Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome

BELL

Ballistic Exercise of the Lower Limb

BELLA

BEfragung zum seeLischen WohLbefinden und VerhAlten

BELLE-2

Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor

BELLE-3

Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor

BELLES

Beyond Endorsed Lipid Lowering with EBCT Scanning trial

BELOB

A randomized phase II study of bevacizumab versus bevacizumab plus lomustine versus lomustine single agent in recurrent glioblastoma

BELOB

Single-agent BEvacizumab or LOmustine versus a combination of Bevacizumab plus lomustine in patients with recurrent glioblastoma

BELSTRESS

BELgian Job STRESS project

BELTRAN

BaskEtbaLl and soccer sTadiums: Registry on Automatic exterNal defibrillators

BEMED

Medical treatment of Meniere's disease with betahistine

BENCHISTA

Benchmarking of Childhood Cancer Survival by Stage

BENCHMARK

Setting a Benchmark for Resource Utilization and Quality of Care in Patients Undergoing TAVI in Europe